Engineered Lactococcus lactis for oral delivery of BoIFN-α/β2: A biotherapeutic strategy for mucosal antiviral defense

Veterinary Microbiology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles